Fludarabine Phosphate (Teva Parenteral Medicines, Inc.)
Welcome to the PulseAid listing for the Fludarabine Phosphate drug offered from Teva Parenteral Medicines, Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Parenteral Medicines, Inc. |
| NON-PROPRIETARY NAME: | Fludarabine Phosphate |
| SUBSTANCE NAME: | FLUDARABINE PHOSPHATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2003-09-12 |
| END MARKETING DATE: | 2018-12-31 |
Fludarabine Phosphate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Fludarabine Phosphate from Teva Parenteral Medicines, Inc. |
| LABELER NAME: | Teva Parenteral Medicines, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/2mL) |
| START MARKETING DATE: | 2003-09-12 |
| END MARKETING DATE: | 2018-12-31 |
| PRODUCT ID: | 0703-5854_e138bb88-2459-440d-ac50-fbb561c4b4b3 |
| PRODUCT NDC: | 0703-5854 |
| APPLICATION NUMBER: | ANDA076349 |
Other FLUDARABINE PHOSPHATE Pharmaceutical Manufacturers / Labelers:
